Envision Healthcare (EVHC) Misses Q3 EPS by 15c, to Review Strategic Alternatives
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
- ServiceNow (NOW) Misses Q3 EPS by 2c, Beats on Revenue; Offers Q4 Revenue Guidance
- Oracle sets $225 billion revenue target for FY30 at investor day
- Amazon (AMZN) Misses Q3 EPS by 7c, Misses on Revenue; Offers Q4 Revenue Guidance
- Rivian shares slip ahead of Thursday earnings release
- Marvell in advanced talks to acquire Lumentum, Bloomberg reports
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
- After-Hours Movers: WDC, BE, DECK, FIX, RNG
Stephens Downgrades Envision Healthcare (EVHC) to Equal Weight
November 2, 2017 7:21 AM EDTStephens downgraded Envision Healthcare (NYSE: EVHC) from Overweight to Equal Weight with a price target of $32.00 (from $70.00).
For an analyst ratings summary and ratings history on Envision Healthcare click here. For more ratings news on Envision Healthcare click here.
Shares of Envision Healthcare closed at $28.03 yesterday.
... MoreBofA/Merrill Lynch Downgrades Envision Healthcare (EVHC) to Neutral
November 2, 2017 6:11 AM EDTBofA/Merrill Lynch downgraded Envision Healthcare (NYSE: EVHC) from Buy to Neutral with a price target of $32.00 (from $48.00).
Analyst Kevin Fischbeck cites weak industry fundamentals for the downgrade and remains concerned with uncertainties surrounding the 2018 ramp. Over the LT the analyst remains positive on... More



